Patents Assigned to ENDO GLOBAL VENTURES
  • Nucleic acid molecules encoding clostridium histolyticum collagenase I and methods of producing the same
    Patent number: 11975054
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: May 7, 2024
    Assignee: ENDO GLOBAL VENTURES
    Inventor: Wayne K. Herber
  • Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same
    Patent number: 11879141
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: January 23, 2024
    Assignee: Endo Global Ventures
    Inventor: Wayne K. Herber
  • Clostridium histolyticum enzymes and methods for the use thereof
    Patent number: 10603365
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: March 31, 2020
    Assignee: ENDO GLOBAL VENTURES
    Inventor: Wayne K. Herber
  • Clostridium histolyticum enzymes and methods for the use thereof
    Patent number: 9757435
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: September 12, 2017
    Assignee: ENDO GLOBAL VENTURES
    Inventor: Wayne K. Herber